A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid
Sign Up to like & getrecommendations! Published in 2018 at "Neurotoxicity Research"
DOI: 10.1007/s12640-018-9922-2
Abstract: Abstractα-Synuclein is a 140-amino acid protein produced predominantly by neurons in the brain which plays a role in the regulation of neurotransmitter release, synaptic function, and plasticity, thus making it the focus in understanding the… read more here.
Keywords: genome wide; synuclein; synuclein levels; levels cerebrospinal ... See more keywords
Ratio of Alpha 2-Macroglobulin Levels in Cerebrospinal Fluid and Serum: An Expression of Neuroinflammation in Acute Disseminated Encephalomyelitis.
Sign Up to like & getrecommendations! Published in 2019 at "Pediatric neurology"
DOI: 10.1016/j.pediatrneurol.2019.04.020
Abstract: BACKGROUND Acute encephalitis and encephalopathy are life-threatening diseases in children. However, no laboratory examinations are performed for their early diagnosis and treatment. Alpha 2-macroglobulin (α2M) is a blood glycoprotein that increases during the early stages… read more here.
Keywords: levels cerebrospinal; disseminated encephalomyelitis; cerebrospinal fluid; acute disseminated ... See more keywords
Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2020 at "Neuropsychopharmacology"
DOI: 10.1038/s41386-020-00867-6
Abstract: Abnormalities in the complement system have been described in patients with schizophrenia, with those individuals having greater frequency of complement component 4A (C4A) alleles and higher C4A transcript levels in postmortem brain tissue. Importantly, abnormalities… read more here.
Keywords: plasma; patients schizophrenia; complement component; csf ... See more keywords
Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cellular Neuroscience"
DOI: 10.3389/fncel.2021.705618
Abstract: Background Neurofilament Light (NfL) chain levels in both cerebrospinal fluid (CSF) and serum have been correlated with the reduction of axonal damage in multiple sclerosis (MS) patients treated with Natalizumab (NTZ). However, little is known… read more here.
Keywords: chain levels; levels cerebrospinal; multiple sclerosis; sclerosis patients ... See more keywords